Ibrutinib
CAS 936563-96-1
Visão geral
Ibrutinib, sold under the brand name Imbruvica among others, is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase, that is important in B cells. It is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia
A Anant Labs fabrica e fornece impurezas de Ibrutinib de alta qualidade para o mercado global. Nossas impurezas EP de Ibrutinib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

















